Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide (vol 26, pg 156, 2023)

被引：1
|
作者：
Pollock, Yaoyao
Smith, Matthew R.
Saad, Fred
Chowdhury, Simon
Oudard, Stephane
Hadaschik, Boris
Olmos, David
Lee, Ji Youl
Uemura, Hiroji
Bhaumik, Amitabha
Londhe, Anil
Rooney, Brendan
Brookman-May, Sabine D.
De Porre, Peter
Mundle, Suneel D.
Small, Eric J.
机构：
[1] University of California San Francisco,The Helen Diller Family Comprehensive Cancer Center
[2] Massachusetts General Hospital Cancer Center and Harvard Medical School,Georges Pompidou Hospital
[3] Centre Hospitalier de l’Université de Montréal,Spanish National Cancer Research Centre (CNIO)
[4] Université de Montréal,Department of Urology, Seoul St. Mary’s Hospital, College of Medicine
[5] Guy’s,undefined
[6] King’s and St. Thomas’ Hospitals,undefined
[7] Great Maze Pond,undefined
[8] University de Paris,undefined
[9] University of Duisburg-Essen,undefined
[10] Essen,undefined
[11] and Ruprecht-Karls-University Heidelberg,undefined
[12] Madrid and Biomedical Research Institute of Málaga (IBIMA),undefined
[13] The Catholic University of Korea,undefined
[14] Yokohama City University Medical Center,undefined
[15] Janssen Research & Development,undefined
[16] Janssen Research & Development,undefined
[17] Janssen Research & Development,undefined
[18] Ludwig-Maximilians-University,undefined
[19] Janssen Research & Development,undefined
[20] Janssen Research & Development,undefined
[21] St. Joseph Health Medical Group,undefined
[22] Providence St. Joseph Health,undefined
来源：
PROSTATE CANCER AND PROSTATIC DISEASES | 2023年 / 26卷 / 04期
关键词：
D O I：
10.1038/s41391-023-00683-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：813 / 813
页数：1
相关论文
共 50 条
  • [1] Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide
    Pollock, YaoYao
    Smith, Matthew R.
    Saad, Fred
    Chowdhury, Simon
    Oudard, Stephane
    Hadaschik, Boris
    Olmos, David
    Lee, Ji Youl
    Uemura, Hiroji
    Bhaumik, Amitabha
    Londhe, Anil
    Rooney, Brendan
    Brookman-May, Sabine D.
    De Porre, Peter
    Mundle, Suneel D.
    Small, Eric J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2023, 26 (01) : 156 - 161
  • [2] Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide
    YaoYao Pollock
    Matthew R. Smith
    Fred Saad
    Simon Chowdhury
    Stéphane Oudard
    Boris Hadaschik
    David Olmos
    Ji Youl Lee
    Hiroji Uemura
    Amitabha Bhaumik
    Anil Londhe
    Brendan Rooney
    Sabine D. Brookman-May
    Peter De Porre
    Suneel D. Mundle
    Eric J. Small
    Prostate Cancer and Prostatic Diseases, 2023, 26 : 156 - 161
  • [3] Correction to: Clinical characteristics associated with falls in patients with non-metastatic castration-resistant prostate cancer treated with apalutamide
    YaoYao Pollock
    Matthew R. Smith
    Fred Saad
    Simon Chowdhury
    Stéphane Oudard
    Boris Hadaschik
    David Olmos
    Ji Youl Lee
    Hiroji Uemura
    Amitabha Bhaumik
    Anil Londhe
    Brendan Rooney
    Sabine D. Brookman-May
    Peter De Porre
    Suneel D. Mundle
    Eric J. Small
    Prostate Cancer and Prostatic Diseases, 2023, 26 : 813 - 813
  • [4] Apalutamide for the Treatment of non-metastatic castration-resistant Prostate Cancer
    Miller, Kurt
    ONKOLOGE, 2019, 25 (03): : 275 - 276
  • [5] Apalutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
    Al-Salama, Zaina T.
    DRUGS, 2019, 79 (14) : 1591 - 1598
  • [6] Apalutamide: A Review in Non-Metastatic Castration-Resistant Prostate Cancer
    Zaina T. Al-Salama
    Drugs, 2019, 79 : 1591 - 1598
  • [7] Apalutamide: Emerging Therapy for Non-Metastatic Castration-Resistant Prostate Cancer
    Alkhudair, Nora A.
    SAUDI PHARMACEUTICAL JOURNAL, 2019, 27 (03) : 368 - 372
  • [8] Apalutamide and overall survival in non-metastatic castration-resistant prostate cancer
    Small, E. J.
    Saad, F.
    Chowdhury, S.
    Oudard, S.
    Hadaschik, B. A.
    Graff, J. N.
    Olmos, D.
    Mainwaring, P. N.
    Lee, J. Y.
    Uemura, H.
    De Porre, P.
    Smith, A. A.
    Zhang, K.
    Lopez-Gitlitz, A.
    Smith, M. R.
    ANNALS OF ONCOLOGY, 2019, 30 (11) : 1813 - 1820
  • [9] Treatment of non-metastatic castration-resistant prostate cancer: focus on apalutamide
    Gul, Anita
    Garcia, Jorge A.
    Barata, Pedro C.
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 7253 - 7262
  • [10] Clinical characteristics and outcomes for patients with non-metastatic castration-resistant prostate cancer
    Arnold, Peter
    Penaloza-Ramos, Maria Cristina
    Adedokun, Lola
    Rees, Sarah
    Lockhat, Mohamed
    Spary, Lisa
    Watkins, Alan
    Gnanapragasam, Vincent
    Crabb, Simon J.
    SCIENTIFIC REPORTS, 2021, 11 (01)
12345